Actinium Pharmaceuticals, Inc.·4

Jul 17, 5:13 PM ET

SETH SANDESH 4

4 · Actinium Pharmaceuticals, Inc. · Filed Jul 17, 2018

Insider Transaction Report

Form 4
Period: 2018-07-13
SETH SANDESH
Director
Transactions
  • Purchase

    Common stock

    2018-07-17$0.79/sh+10,000$7,900143,333 total
  • Award

    Options to purchase common stock

    2018-07-13$0.78/sh+1,000,000$782,9001,000,000 total
    Exercise: $0.78From: 2018-07-13Exp: 2028-07-13Common Stock (1,000,000 underlying)
Footnotes (1)
  • [F1]Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options vest each month from the date of grant.

Documents

1 file
  • 4
    ownership.xmlPrimary